VOYA Investment Management Portfolio holdings
AUM
$100B
This Quarter Return
+7.39%
1 Year Return
+30.07%
3 Year Return
+120.64%
5 Year Return
+214.86%
10 Year Return
+564.47%
AUM
$96.3B
AUM Growth
+$96.3B
(-0.43%)
Cap. Flow
-$1.83B
Cap. Flow
% of AUM
-1.9%
Top 10 Holdings %
Top 10 Hldgs %
26.4%
Holding
2,875
New
49
Increased
612
Reduced
1,941
Closed
111
Top Buys
Top Sells
| 1 |
Tesla
TSLA
|
$485M |
| 2 |
Apple
AAPL
|
$402M |
| 3 |
Meta Platforms (Facebook)
META
|
$361M |
| 4 |
Marvell Technology
MRVL
|
$285M |
| 5 |
Zscaler
ZS
|
$265M |
Sector Composition
| 1 | Technology | 32.56% |
| 2 | Financials | 9.84% |
| 3 | Consumer Discretionary | 9.4% |
| 4 | Healthcare | 8.11% |
| 5 | Communication Services | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2576
NN Inc
NNBR
$129M
| $47.1K | ﹤0.01% | +14,409 | New | +$47.1K |
|
2577
Wheels Up
UP
$2.05B
| $47K | ﹤0.01% | 28,456 -1,114 | -4% | -$1.84K |
|
2578
Tango Therapeutics
TNGX
$747M
| $46.8K | ﹤0.01% | 15,149 -1,162 | -7% | -$3.59K |
|
2579
Cardlytics
CDLX
$54.3M
| $46.7K | ﹤0.01% | 12,597 -629 | -5% | -$2.33K |
|
|
TSVT
2580
DELISTED
2seventy bio
TSVT
| $46.6K | ﹤0.01% | 15,857 -653 | -4% | -$1.92K |
|
2581
Puma Biotechnology
PBYI
$254M
| $45.1K | ﹤0.01% | 14,778 -825 | -5% | -$2.52K |
|
2582
Achieve Life Sciences
ACHV
$152M
| $44.9K | ﹤0.01% | 12,749 -1,260 | -9% | -$4.44K |
|
|
NVRO
2583
DELISTED
NEVRO CORP.
NVRO
| $44.1K | ﹤0.01% | 11,862 -571 | -5% | -$2.12K |
|
2584
E.W. Scripps
SSP
$264M
| $43.3K | ﹤0.01% | 19,580 -1,178 | -6% | -$2.6K |
|
2585
X4 Pharmaceuticals
XFOR
$84.2M
| $43.1K | ﹤0.01% | 58,702 | – | – |
|
|
IAUX
2586
i-80 Gold Corp
IAUX
$653M
| $43K | ﹤0.01% | 88,713 -3,823 | -4% | -$1.85K |
|
2587
Destination XL Group
DXLG
$69.4M
| $42.4K | ﹤0.01% | 15,766 -8,558 | -35% | -$23K |
|
2588
Caribou Biosciences
CRBU
$174M
| $42.3K | ﹤0.01% | 26,578 -1,225 | -4% | -$1.95K |
|
2589
Ventyx Biosciences
VTYX
$171M
| $42.1K | ﹤0.01% | 19,208 -1,337 | -7% | -$2.93K |
|
2590
Atossa Therapeutics
ATOS
$98.5M
| $41.8K | ﹤0.01% | 44,232 -2,117 | -5% | -$2K |
|
2591
Nkarta
NKTX
$151M
| $41.1K | ﹤0.01% | 16,497 -1,010 | -6% | -$2.52K |
|
2592
Blink Charging
BLNK
$124M
| $41.1K | ﹤0.01% | 29,533 -3,025 | -9% | -$4.21K |
|
2593
Sight Sciences
SGHT
$213M
| $40.5K | ﹤0.01% | 11,125 -617 | -5% | -$2.25K |
|
2594
The Beauty Health Co
SKIN
$264M
| $40.1K | ﹤0.01% | 25,248 | – | – |
|
2595
TScan Therapeutics
TCRX
$102M
| $38.9K | ﹤0.01% | 12,786 -1,125 | -8% | -$3.42K |
|
2596
WM Technology
MAPS
$134M
| $38.6K | ﹤0.01% | +27,993 | New | +$38.6K |
|
2597
Zura Bio
ZURA
$133M
| $38.6K | ﹤0.01% | 15,439 +1,524 | +11% | +$3.81K |
|
2598
Metagenomi
MGX
$65.3M
| $37.2K | ﹤0.01% | +10,314 | New | +$37.2K |
|
|
RGLS
2599
DELISTED
Regulus Therapeutics
RGLS
| $36.5K | ﹤0.01% | 23,074 | – | – |
|
2600
Forge Global Holdings
FRGE
$254M
| $35.7K | ﹤0.01% | 38,395 -2,228 | -5% | -$2.07K |
|